Moreover, decreased level of NLRP6 was correlated with unfavorable prognosis in patients with head and neck squamous cell carcinoma (NHSCC), revealing the tumor suppressive role of NLRP6 in gastric cancer and NHSCC [25]. Here, NLRP6 is linked to head and neck squamous cell carcinoma.